| AstraZeneca PLC (AZN) |
GB |
$262.317B |
18.51 |
| Amgen Inc. (AMGN) |
US |
$172.422B |
14.64 |
| Gilead Sciences, Inc. (GILD) |
US |
$147.458B |
14.51 |
| Vertex Pharmaceuticals (VRTX) |
United States |
$103.890B |
26.75 |
| Bristol Myers Squibb Company (BMY) |
US |
$95.049B |
7.12 |
| GSK PLC Sponsored ADR (GSK) |
GB |
$94.785B |
10.53 |
| Regeneron Pharmaceuticals, Inc. (REGN) |
US |
$69.690B |
17.93 |
| Alnylam Pharmaceuticals, Inc. (ALNY) |
US |
$58.487B |
1924.78 |
| CSL Limited Sponsored ADR (CSLLY) |
AU |
$56.375B |
0.00 |
| argenex SE (ARGX) |
NL |
$52.620B |
65.34 |
| Insmed, Inc. (INSM) |
US |
$40.458B |
0.00 |
| Novozymes A/S (NVZMY) |
DK |
$30.060B |
0.00 |
| BioNTech SE Sponsored ADR (BNTX) |
DE |
$23.225B |
0.00 |
| Biogen Inc. (BIIB) |
US |
$22.814B |
9.29 |
| Royalty Pharma (RPRX) |
United States |
$22.487B |
8.53 |
| Incyte Corporation (INCY) |
US |
$20.806B |
19.92 |
| Genmab A/S (GNMSF) |
DK |
$19.195B |
14.08 |
| Illumina, Inc. (ILMN) |
US |
$18.626B |
27.96 |
| Genmab A/S Sponsored ADR (GMAB) |
DK |
$18.402B |
13.85 |
| Roivant Sciences (ROIV) |
United Kingdom |
$14.081B |
0.00 |
| Exact Sciences Corporation (EXAS) |
US |
$12.539B |
348.32 |
| Swedish Orphan Biovitrum (BIOVF) |
SE |
$12.417B |
23.10 |
| Ascendis Pharma A/S (ASND) |
DK |
$12.200B |
0.00 |
| Guardant Health, Inc. (GH) |
US |
$12.191B |
0.00 |
| Revolution Medicines (RVMD) |
United States |
$11.794B |
0.00 |
| Exelixis, Inc. (EXEL) |
US |
$10.942B |
17.52 |
| Avidity Biosciences (RNA) |
United States |
$10.190B |
0.00 |
| BioMarin Pharmaceutical Inc. (BMRN) |
US |
$9.886B |
17.93 |
| QIAGEN N.V. (QGEN) |
NL |
$9.683B |
18.38 |
| Moderna, Inc. (MRNA) |
US |
$9.585B |
0.00 |
| Bio-Techne Corp (TECH) |
United States |
$8.945B |
33.38 |
| Metsera Inc. (MTSR) |
US |
$8.758B |
0.00 |
| Bio-Rad Laboratories, Inc. (BIO.B) |
US |
$8.311B |
29.62 |
| Abivax SA Sponsored ADR (ABVX) |
FR |
$8.193B |
0.00 |
| Repligen (RGEN) |
United States |
$8.039B |
86.04 |
| Halozyme Therapeutics, Inc. (HALO) |
US |
$8.025B |
12.83 |
| Jazz Pharmaceuticals PLC (JAZZ) |
IE |
$7.970B |
31.08 |
| Cytokinetics, Incorporated (CYTK) |
US |
$7.355B |
0.00 |
| Merus N.V. (MRUS) |
NL |
$7.223B |
0.00 |
| Axsome Therapeutics, Inc. (AXSM) |
US |
$6.965B |
0.00 |
| Nuvalent, Inc. (NUVL) |
US |
$6.731B |
0.00 |
| Rhythm Pharmaceuticals (RYTM) |
United States |
$6.694B |
0.00 |
| Regencell Bioscience Holdings (RGC) |
Hong Kong, SAR China |
$6.438B |
0.00 |
| Legend Biotech Corporation Sponsored ADR (LEGN) |
US |
$5.869B |
0.00 |
| PTC Therapeutics, Inc. (PTCT) |
US |
$5.763B |
7.83 |
| Krystal Biotech, Inc. (KRYS) |
US |
$5.740B |
29.67 |
| Vaxcyte, Inc. (PCVX) |
US |
$5.452B |
0.00 |
| Alkermes plc (ALKS) |
IE |
$5.431B |
15.97 |
| Arrowhead Pharmaceuticals, Inc. (ARWR) |
US |
$5.424B |
0.00 |
| TG Therapeutics (TGTX) |
United States |
$5.118B |
11.60 |
| CRISPR Therapeutics AG (CRSP) |
CH |
$5.013B |
0.00 |
| Arcellx, Inc. (ACLX) |
US |
$5.005B |
0.00 |
| Protagonist Therapeutics, Inc. (PTGX) |
US |
$4.948B |
128.29 |
| Zealand Pharma (ZLDPF) |
Denmark |
$4.769B |
4.72 |
| Akero Therapeutics, Inc. (AKRO) |
US |
$4.323B |
0.00 |
| Kymera Therapeutics, Inc. (KYMR) |
US |
$4.221B |
0.00 |
| Praxis Precision Medicines, Inc. (PRAX) |
US |
$4.207B |
0.00 |
| Viking Therapeutics (VKTX) |
United States |
$4.156B |
0.00 |
| Immunovant, Inc. (IMVT) |
US |
$4.070B |
0.00 |
| Ligand Pharmaceuticals Incorporated (LGND) |
US |
$3.968B |
97.82 |
| ACADIA Pharmaceuticals Inc. (ACAD) |
US |
$3.808B |
32.24 |
| Belite Bio, Inc. Sponsored ADR (BLTE) |
US |
$3.604B |
0.00 |
| Mirum Pharmaceuticals, Inc. (MIRM) |
US |
$3.500B |
0.00 |
| ADMA Biologics Inc (ADMA) |
US |
$3.465B |
24.61 |
| Telix Pharmaceuticals (TLX) |
Australia |
$3.286B |
0.00 |
| Celcuity, Inc. (CELC) |
US |
$3.162B |
0.00 |
| CG Oncology, Inc. (CGON) |
US |
$3.026B |
0.00 |
| Arcutis Biotherapeutics, Inc. (ARQT) |
US |
$2.968B |
0.00 |
| Ascentage Pharma Group International - Unsponsored ADR (AAPG) |
CN |
$2.961B |
0.00 |
| Xenon Pharmaceuticals (XENE) |
Canada |
$2.956B |
0.00 |
| Jyong Biotech Ltd. (MENS) |
TW |
$2.955B |
0.00 |
| Ultragenyx Pharmaceutical Inc. (RARE) |
US |
$2.955B |
0.00 |
| Disc Medicine, Inc. (IRON) |
US |
$2.915B |
0.00 |
| Tarsus Pharmaceuticals (TARS) |
United States |
$2.897B |
0.00 |
| Travere Therapeutics (TVTX) |
United States |
$2.894B |
0.00 |
| GRAIL, Inc. (GRAL) |
US |
$2.862B |
0.00 |
| Kiniksa Pharmaceuticals International, plc (KNSA) |
GB |
$2.844B |
85.27 |
| Scholar Rock Holding (SRRK) |
United States |
$2.783B |
0.00 |
| Amicus Therapeutics, Inc. (FOLD) |
US |
$2.737B |
221.75 |
| IDEAYA Biosciences, Inc. (IDYA) |
US |
$2.651B |
0.00 |
| Cidara Therapeutics, Inc. (CDTX) |
US |
$2.647B |
0.00 |
| Viridian Therapeutics (VRDN) |
United States |
$2.619B |
0.00 |
| HUTCHMED (China) Limited Sponsored ADR (HCM) |
HK |
$2.608B |
0.00 |
| Apogee Therapeutics Inc. (APGE) |
US |
$2.523B |
0.00 |
| Mineralys Therapeutics, Inc. (MLYS) |
US |
$2.521B |
0.00 |
| Anbio Biotechnology (NNNN) |
DE |
$2.461B |
0.00 |
| Zai Lab (ZLAB) |
China |
$2.448B |
0.00 |
| Apellis Pharmaceuticals, Inc. (APLS) |
US |
$2.437B |
62.13 |
| Agios Pharmaceuticals, Inc. (AGIO) |
US |
$2.372B |
0.00 |
| Bavarian Nordic (BVNRY) |
DK |
$2.308B |
11.16 |
| Liquidia Corporation (LQDA) |
US |
$2.270B |
0.00 |
| Adaptive Biotechnologies Corporation (ADPT) |
US |
$2.258B |
0.00 |
| Beam Therapeutics Inc. (BEAM) |
US |
$2.254B |
0.00 |
| Denali Therapeutics Inc. (DNLI) |
US |
$2.196B |
0.00 |
| ImmunityBio, Inc. (IBRX) |
US |
$2.098B |
0.00 |
| Arcus Biosciences, Inc. (RCUS) |
US |
$2.085B |
0.00 |
| Recursion Pharmaceuticals (RXRX) |
United States |
$2.006B |
0.00 |
| Vericel (VCEL) |
United States |
$1.965B |
162.25 |
| ANI Pharmaceuticals, Inc. (ANIP) |
US |
$1.962B |
15.75 |
| Structure Therapeutics Inc. Sponsored ADR (GPCR) |
US |
$1.892B |
0.00 |
| Mesoblast Limited (MESO) |
AU |
$1.874B |
0.00 |
| Twist Bioscience (TWST) |
United States |
$1.827B |
0.00 |
| Harmony Biosciences Holdings, Inc. (HRMY) |
US |
$1.810B |
9.88 |
| Edgewise Therapeutics, Inc. (EWTX) |
US |
$1.808B |
0.00 |
| MannKind Corporation (MNKD) |
US |
$1.729B |
56.30 |
| Sarepta Therapeutics (SRPT) |
United States |
$1.723B |
0.00 |
| Alvotech (ALVO) |
LU |
$1.721B |
12.98 |
| Immunocore Holdings PLC Sponsored ADR (IMCR) |
GB |
$1.688B |
0.00 |
| Cogent Biosciences, Inc. (COGT) |
US |
$1.687B |
0.00 |
| Nuvation Bio Inc. (NUVB) |
US |
$1.619B |
0.00 |
| Terns Pharmaceuticals (TERN) |
United States |
$1.616B |
0.00 |
| Janux Therapeutics, Inc. (JANX) |
US |
$1.591B |
0.00 |
| Sionna Therapeutics (SION) |
United States |
$1.549B |
0.00 |
| Vera Therapeutics (VERA) |
United States |
$1.544B |
0.00 |
| uniQure N.V. (QURE) |
NL |
$1.525B |
0.00 |
| Celldex Therapeutics, Inc. (CLDX) |
US |
$1.521B |
0.00 |
| Zenas BioPharma (ZBIO) |
United States |
$1.415B |
0.00 |
| Certara, Inc. (CERT) |
US |
$1.393B |
25.50 |
| Spyre Therapeutics (SYRE) |
United States |
$1.360B |
0.00 |
| Trevi Therapeutics (TRVI) |
United States |
$1.341B |
0.00 |
| Immunome, Inc. (IMNM) |
US |
$1.327B |
0.00 |
| Syndax Pharmaceuticals (SNDX) |
United States |
$1.307B |
0.00 |
| Stoke Therapeutics (STOK) |
United States |
$1.306B |
34.12 |
| NeoGenomics, Inc. (NEO) |
US |
$1.304B |
0.00 |
| Dynavax Technologies Corporation (DVAX) |
US |
$1.272B |
37.34 |
| Maze Therapeutics, Inc. (MAZE) |
US |
$1.254B |
0.00 |
| WAVE Life Sciences (WVE) |
Singapore |
$1.251B |
0.00 |
| Upstream Bio (UPB) |
United States |
$1.241B |
0.00 |
| Zymeworks (ZYME) |
United States |
$1.237B |
0.00 |
| NovoCure Limited (NVCR) |
JE |
$1.223B |
0.00 |
| Oric Pharmaceuticals, Inc. (ORIC) |
US |
$1.199B |
0.00 |
| CureVac N.V. (CVAC) |
DE |
$1.169B |
5.43 |
| Inhibrx Biosciences, Inc. (INBX) |
US |
$1.169B |
0.00 |
| AbCellera Biologics Inc. (ABCL) |
CA |
$1.168B |
0.00 |
| Dianthus Therapeutics, Inc. (DNTH) |
US |
$1.168B |
0.00 |
| Precigen, Inc. (PGEN) |
US |
$1.162B |
0.00 |
| Pharvaris N.V. (PHVS) |
NL |
$1.129B |
0.00 |
| MiMedx Group, Inc (MDXG) |
US |
$1.102B |
19.58 |
| Immatics N.V. (IMTX) |
DE |
$1.100B |
0.00 |
| AnaptysBio, Inc. (ANAB) |
US |
$1.098B |
0.00 |
| Urogen Pharma (URGN) |
United States |
$1.075B |
0.00 |
| Tango Therapeutics (TNGX) |
United States |
$1.059B |
0.00 |
| Pharming Group N.V. Sponsored ADR (PHAR) |
NL |
$1.057B |
0.00 |
| Fortrea Holdings Inc. (FTRE) |
US |
$1.040B |
22.06 |
| Pharming Group NV (PHGUF) |
NL |
$1.027B |
153.00 |
| Intellia Therapeutics, Inc. (NTLA) |
US |
$1.022B |
0.00 |
| Oculis Holding AG (OCS) |
CH |
$1.007B |
0.00 |
| Day One Biopharmaceuticals, Inc. (DAWN) |
US |
$0.999B |
0.00 |
| Pacira BioSciences, Inc. (PCRX) |
US |
$0.991B |
10.86 |
| Rezolute (RZLT) |
United States |
$0.977B |
0.00 |
| Sana Biotechnology (SANA) |
United States |
$0.973B |
0.00 |
| Castle Biosciences, Inc. (CSTL) |
US |
$0.964B |
132.16 |
| BridgeBio Oncology Therapeutics, Inc (BBOT) |
US |
$0.962B |
0.00 |
| Nanobiotix S.A. - Sponsored ADR (NBTX) |
FR |
$0.953B |
0.00 |
| Nurix Therapeutics, Inc. (NRIX) |
US |
$0.946B |
0.00 |
| BGM Group Ltd. (BGM) |
CN |
$0.943B |
0.00 |
| Phathom Pharmaceuticals, Inc. (PHAT) |
US |
$0.943B |
0.00 |
| Rapport Therapeutics, Inc. (RAPP) |
US |
$0.937B |
0.00 |
| Kodiak Sciences Inc. (KOD) |
US |
$0.931B |
0.00 |
| Oxford BioMedica (OXBDF) |
GB |
$0.922B |
0.00 |
| Mind Medicine (MindMed) Inc. (MNMD) |
US |
$0.890B |
0.00 |
| Biohaven Ltd. (BHVN) |
US |
$0.874B |
0.00 |
| Arbutus Biopharma Corporation (ABUS) |
US |
$0.863B |
0.00 |
| Palvella Therapeutics, Inc. (PVLA) |
US |
$0.861B |
0.00 |
| MBX Biosciences, Inc. (MBX) |
US |
$0.859B |
0.00 |
| Kura Oncology, Inc. (KURA) |
US |
$0.858B |
0.00 |
| CorMedix Inc (CRMD) |
US |
$0.843B |
14.35 |
| Iovance Biotherapeutics, Inc. (IOVA) |
US |
$0.832B |
0.00 |
| Septerna (SEPN) |
United States |
$0.825B |
0.00 |
| Bicara Therapeutics Inc. (BCAX) |
US |
$0.800B |
0.00 |
| Basilea Pharmaceutica AG (BPMUF) |
CH |
$0.790B |
0.00 |
| EYEPOINT PHARMACEUTICALS, INC. (EYPT) |
US |
$0.773B |
0.00 |
| Tyra Biosciences (TYRA) |
United States |
$0.764B |
0.00 |
| Monte Rosa Therapeutics, Inc. (GLUE) |
US |
$0.760B |
38.47 |
| ArriVent BioPharma, Inc. (AVBP) |
US |
$0.732B |
0.00 |
| LENZ Therapeutics, Inc. (LENZ) |
US |
$0.719B |
0.00 |
| Vir Biotechnology (VIR) |
United States |
$0.713B |
0.00 |
| Astria Therapeutics, Inc. (ATXS) |
US |
$0.706B |
0.00 |
| GH Research PLC (GHRS) |
IE |
$0.702B |
0.00 |
| Gyre Therapeutics, Inc. (GYRE) |
US |
$0.694B |
90.12 |
| MoonLake Immunotherapeutics (MLTX) |
CH |
$0.683B |
0.00 |
| Arvinas, Inc. (ARVN) |
US |
$0.683B |
0.00 |
| Geron Corporation (GERN) |
US |
$0.683B |
0.00 |
| MeiraGTx Holdings PLC (MGTX) |
US |
$0.681B |
0.00 |
| Replimune Group, Inc. (REPL) |
US |
$0.649B |
0.00 |
| Sinovac Biotech (SVA) |
China |
$0.645B |
0.00 |
| Erasca, Inc. (ERAS) |
US |
$0.644B |
0.00 |
| Anavex Life Sciences Corp. (AVXL) |
US |
$0.626B |
0.00 |
| Ventyx Biosciences (VTYX) |
United States |
$0.625B |
0.00 |
| CytomX Therapeutics, Inc. (CTMX) |
US |
$0.597B |
9.05 |
| Cytek Biosciences, Inc. (CTKB) |
US |
$0.591B |
0.00 |
| Myriad Genetics, Inc. (MYGN) |
US |
$0.587B |
0.00 |
| Compass Therapeutics, Inc. (CMPX) |
US |
$0.585B |
0.00 |
| Opthea Limited Unsponsored ADR (OPT) |
AU |
$0.583B |
0.00 |
| Olema Pharmaceuticals, Inc. (OLMA) |
US |
$0.573B |
0.00 |
| Prothena Corporation plc (PRTA) |
IE |
$0.568B |
0.00 |
| Corvus Pharmaceuticals, Inc. (CRVS) |
US |
$0.568B |
0.00 |
| REGENXBIO (RGNX) |
United States |
$0.566B |
0.00 |
| Inventiva S.A. Sponsored ADR (IVA) |
FR |
$0.558B |
0.00 |
| Gossamer Bio, Inc. (GOSS) |
US |
$0.546B |
0.00 |
| Niagen Bioscience, Inc. (NAGE) |
US |
$0.546B |
42.75 |
| Verastem (VSTM) |
United States |
$0.539B |
0.00 |
| Emergent Biosolutions Inc. (EBS) |
US |
$0.534B |
5.13 |
| Ginkgo Bioworks Holdings, Inc. (DNA) |
US |
$0.530B |
0.00 |
| Prime Medicine, Inc. (PRME) |
US |
$0.513B |
0.00 |
| Monopar Therapeutics Inc. (MNPR) |
US |
$0.499B |
0.00 |
| Absci Corporation (ABSI) |
US |
$0.499B |
0.00 |
| Keros Therapeutics, Inc. (KROS) |
US |
$0.494B |
10.52 |
| Alumis Inc. (ALMS) |
US |
$0.491B |
0.00 |
| Rapt Therapeutics (RAPT) |
US |
$0.477B |
0.00 |
| DBV Technologies S.A. (DBVT) |
FR |
$0.473B |
0.00 |
| NovaBridge Biosciences (NBP) |
US |
$0.461B |
0.00 |
| ADC Therapeutics SA (ADCT) |
CH |
$0.455B |
0.00 |
| Lexicon Pharmaceuticals, Inc. (LXRX) |
US |
$0.454B |
0.00 |
| Eton Pharmaceuticals, Inc. (ETON) |
US |
$0.453B |
0.00 |
| Bicycle Therapeutics PLC Sponsored ADR (BCYC) |
GB |
$0.446B |
0.00 |
| Design Therapeutics, Inc. (DSGN) |
US |
$0.431B |
0.00 |
| Ocugen, Inc. (OCGN) |
US |
$0.425B |
0.00 |
| Cullinan Therapeutics, Inc. (CGEM) |
US |
$0.425B |
0.00 |
| PureTech Health PLC Sponsored ADR (PRTC) |
US |
$0.423B |
0.00 |
| Neumora Therapeutics, Inc. (NMRA) |
US |
$0.415B |
0.00 |
| Bright Minds Biosciences Inc. (DRUG) |
US |
$0.414B |
0.00 |
| Fulcrum Therapeutics, Inc. (FULC) |
US |
$0.413B |
0.00 |
| XOMA Royalty (XOMA) |
United States |
$0.401B |
0.00 |
| Kamada Ltd. (KMDA) |
IL |
$0.383B |
19.59 |
| Neurogene Inc. (NGNE) |
US |
$0.382B |
0.00 |
| Northwest Biotherapeutics, Inc. (NWBO) |
US |
$0.375B |
0.00 |
| Tectonic Therapeutic (TECX) |
United States |
$0.362B |
0.00 |
| Autolus Therapeutics PLC Sponsored ADR (AUTL) |
GB |
$0.354B |
0.00 |
| LB Pharmaceuticals Inc (LBRX) |
US |
$0.345B |
0.00 |
| Rocket Pharmaceuticals, Inc. (RCKT) |
US |
$0.342B |
0.00 |
| Invivyd, Inc. (IVVD) |
US |
$0.340B |
0.00 |
| Benitec Biopharma Limited (BNTC) |
US |
$0.336B |
0.00 |
| Aura Biosciences, Inc. (AURA) |
US |
$0.332B |
0.00 |
| AC Immune (ACIU) |
CH |
$0.331B |
0.00 |
| Amarin Corporation PLC (AMRN) |
IE |
$0.325B |
0.00 |
| Annexon, Inc. (ANNX) |
US |
$0.316B |
0.00 |
| Solid Biosciences (SLDB) |
United States |
$0.316B |
0.00 |
| Alto Neuroscience, Inc. (ANRO) |
US |
$0.313B |
0.00 |
| enGene Holdings Inc. (ENGN) |
CA |
$0.310B |
0.00 |
| Contineum Therapeutics, Inc. (CTNM) |
US |
$0.306B |
0.00 |
| DiaMedica Therapeutics, Inc. (DMAC) |
US |
$0.306B |
0.00 |
| Puma Biotechnology, Inc. (PBYI) |
US |
$0.302B |
8.09 |
| Jade Biosciences, Inc. (JBIO) |
US |
$0.300B |
0.00 |
| Immuneering Corporation (IMRX) |
US |
$0.286B |
0.00 |
| Mereo BioPharma Group plc - Sponsored ADR (MREO) |
GB |
$0.286B |
0.00 |
| Kyverna Therapeutics, Inc. (KYTX) |
US |
$0.285B |
0.00 |
| Candel Therapeutics, Inc. (CADL) |
US |
$0.277B |
0.00 |
| Entrada Therapeutics (TRDA) |
United States |
$0.263B |
0.00 |
| Allogene Therapeutics, Inc. (ALLO) |
US |
$0.262B |
0.00 |
| BioAge Labs, Inc. (BIOA) |
US |
$0.260B |
0.00 |
| Vanda Pharmaceuticals (VNDA) |
United States |
$0.260B |
0.00 |
| Atea Pharmaceuticals, Inc. (AVIR) |
US |
$0.260B |
0.00 |
| Crescent Biopharma, Inc. (CBIO) |
US |
$0.257B |
0.00 |
| Lifecore Biomedical, Inc. (LFCR) |
US |
$0.257B |
0.00 |
| Alpha Teknova (TKNO) |
United States |
$0.252B |
0.00 |
| Prima BioMed Ltd (IMMP) |
AU |
$0.249B |
0.00 |
| Foghorn Therapeutics Inc. (FHTX) |
US |
$0.247B |
0.00 |
| Sagimet Biosciences (SGMT) |
United States |
$0.245B |
0.00 |
| Zura Bio (ZURA) |
United States |
$0.239B |
0.00 |
| Arcturus Therapeutics Holdings Inc. (ARCT) |
US |
$0.237B |
0.00 |
| Enanta Pharmaceuticals, Inc. (ENTA) |
US |
$0.235B |
0.00 |
| Voyager Therapeutics (VYGR) |
United States |
$0.235B |
0.00 |
| ProQR Therapeutics N.V. (PRQR) |
NL |
$0.234B |
0.00 |
| Cabaletta Bio, Inc. (CABA) |
US |
$0.233B |
0.00 |
| Adherex Technologies Inc. (FENC) |
US |
$0.224B |
0.00 |
| Editas Medicine, Inc. (EDIT) |
US |
$0.222B |
0.00 |
| Black Diamond Therapeutics, Inc. (BDTX) |
US |
$0.221B |
10.81 |
| Aardvark Therapeutics, Inc. (AARD) |
US |
$0.220B |
0.00 |
| Adocia (ADOCY) |
FR |
$0.216B |
0.00 |
| Abeona Therapeutics Inc. (ABEO) |
US |
$0.215B |
4.57 |
| Humacyte, Inc. (HUMA) |
US |
$0.211B |
0.00 |
| Tenaya Therapeutics (TNYA) |
United States |
$0.209B |
0.00 |
| Prenetics Global Limited (PRE) |
HK |
$0.208B |
0.00 |
| Genelux Corporation (GNLX) |
US |
$0.206B |
0.00 |
| Cartesian Therapeutics (RNAC) |
United States |
$0.205B |
0.00 |
| Tiziana Life Sciences (TLSA) |
United Kingdom |
$0.204B |
0.00 |
| SELLAS Life Sciences (SLS) |
United States |
$0.199B |
0.00 |
| Eupraxia Pharmaceuticals Inc. (EPRX) |
CA |
$0.196B |
0.00 |
| Caribou Biosciences, Inc. (CRBU) |
US |
$0.195B |
0.00 |
| GENFIT S.A. Unsponsored ADR (GNFT) |
FR |
$0.195B |
0.00 |
| Molecular Partners AG Sponsored ADR (MOLN) |
CH |
$0.191B |
0.00 |
| Nautilus Biotechnology, Inc. (NAUT) |
US |
$0.191B |
0.00 |
| C4 Therapeutics, Inc. (CCCC) |
US |
$0.167B |
0.00 |
| Innate Pharma S.A. Sponsored ADR (IPHA) |
FR |
$0.164B |
0.00 |
| Nuvectis Pharma, Inc. (NVCT) |
US |
$0.157B |
0.00 |
| Coherus Oncology, Inc. (CHRS) |
US |
$0.156B |
0.00 |
| MaxCyte, Inc. (MXCT) |
US |
$0.154B |
0.00 |
| Codexis, Inc. (CDXS) |
US |
$0.153B |
0.00 |
| PepGen, Inc. (PEPG) |
US |
$0.152B |
0.00 |
| Forte Biosciences, Inc. (FBRX) |
US |
$0.150B |
0.00 |
| Orchestra BioMed Holdings, Inc. (OBIO) |
US |
$0.147B |
0.00 |
| Cardiff Oncology, Inc. (CRDF) |
US |
$0.146B |
0.00 |
| Milestone Pharmaceuticals Inc. (MIST) |
CA |
$0.145B |
0.00 |
| Rani Therapeutics Holdings, Inc. (RANI) |
US |
$0.145B |
0.00 |
| Elicio Therapeutics, Inc. (ELTX) |
US |
$0.145B |
0.00 |
| Compugen Ltd. (CGEN) |
IL |
$0.145B |
0.00 |
| Entera Bio Ltd. (ENTX) |
IL |
$0.143B |
0.00 |
| Actuate Therapeutics, Inc. (ACTU) |
US |
$0.143B |
0.00 |
| Scilex Holding (SCLX) |
United States |
$0.143B |
0.00 |
| Sangamo Therapeutics (SGMO) |
United States |
$0.142B |
0.00 |
| Anika Therapeutics Inc. (ANIK) |
US |
$0.142B |
0.00 |
| Nkarta, Inc. (NKTX) |
US |
$0.139B |
0.00 |
| Spero Therapeutics (SPRO) |
United States |
$0.138B |
0.00 |
| ANIXA BIOSCIENCES INC (ANIX) |
US |
$0.138B |
0.00 |
| Alector, Inc. (ALEC) |
US |
$0.130B |
0.00 |
| TuHURA Biosciences, Inc. (HURA) |
US |
$0.129B |
0.00 |
| Vor Biopharma (VOR) |
|
$0.128B |
0.00 |
| Seres Therapeutics, Inc. (MCRB) |
US |
$0.127B |
0.00 |
| Agenus Inc. (AGEN) |
US |
$0.127B |
0.00 |
| Climb Bio, Inc. (CLYM) |
US |
$0.124B |
0.00 |
| Fate Therapeutics, Inc. (FATE) |
US |
$0.123B |
0.00 |
| Eledon Pharmaceuticals, Inc. (ELDN) |
US |
$0.123B |
0.00 |
| Applied Therapeutics Inc. (APLT) |
US |
$0.122B |
0.00 |
| VistaGen Therapeutics (VTGN) |
United States |
$0.122B |
0.00 |
| Cognition Therapeutics, Inc. (CGTX) |
US |
$0.122B |
0.00 |
| Greenwich LifeSciences, Inc. (GLSI) |
US |
$0.120B |
0.00 |
| Opus Genetics, Inc. (IRD) |
US |
$0.120B |
0.00 |
| Alpha Cognition Inc. (ACOG) |
CA |
$0.120B |
0.00 |
| Seer (SEER) |
United States |
$0.118B |
0.00 |
| eXoZymes Inc. (EXOZ) |
US |
$0.117B |
0.00 |
| BioHarvest Sciences Inc. (BHST) |
CA |
$0.117B |
0.00 |
| Citius Oncology, Inc. (CTOR) |
US |
$0.117B |
0.00 |
| Acumen Pharmaceuticals, Inc. (ABOS) |
US |
$0.114B |
0.00 |
| Inovio Pharmaceuticals, Inc. (INO) |
US |
$0.113B |
0.00 |
| Turn Therapeutics (TTRX) |
United States |
$0.113B |
0.00 |
| Estrella Immunopharma, Inc. (ESLA) |
US |
$0.109B |
0.00 |
| Immix Biopharma, Inc. (IMMX) |
US |
$0.104B |
0.00 |
| VTv Therapeutics (VTVT) |
United States |
$0.102B |
0.00 |
| Oncolytics Biotech Inc. (ONCY) |
CA |
$0.102B |
0.00 |
| Instil Bio (TIL) |
United States |
$0.102B |
0.00 |
| Anebulo Pharmaceuticals, Inc. (ANEB) |
US |
$0.099B |
0.00 |
| Clene Inc. (CLNN) |
US |
$0.099B |
0.00 |
| Pliant Therapeutics, Inc. (PLRX) |
US |
$0.098B |
0.00 |
| Tevogen Bio Holdings (TVGN) |
United States |
$0.098B |
0.00 |
| Whitehawk Therapeutics (WHWK) |
United States |
$0.098B |
0.00 |
| Biomea Fusion, Inc. (BMEA) |
US |
$0.097B |
0.00 |
| Zhengye Biotechnology Holding (ZYBT) |
China |
$0.097B |
0.00 |
| Coya Therapeutics, Inc. (COYA) |
US |
$0.096B |
0.00 |
| Starpharma Holdings (SPHRY) |
Australia |
$0.096B |
0.00 |
| Shattuck Labs (STTK) |
United States |
$0.095B |
0.00 |
| Ovid Therapeutics (OVID) |
US |
$0.094B |
0.00 |
| Zentalis Pharmaceuticals (ZNTL) |
United States |
$0.092B |
0.00 |
| OKYO Pharma Limited Sponsored ADR (OKYO) |
|
$0.092B |
0.00 |
| Adverum Biotechnologies, Inc. (ADVM) |
US |
$0.091B |
0.00 |
| 23andMe Holding Co. (MEHCQ) |
US |
$0.090B |
0.00 |
| Kalaris Therapeutics Inc. (KLRS) |
US |
$0.089B |
0.00 |
| Connect Biopharma Holdings Limited Sponsored ADR (CNTB) |
US |
$0.086B |
0.00 |
| CAMP4 Therapeutics Corporation (CAMP) |
US |
$0.086B |
0.00 |
| Artiva Biotherapeutics, Inc. (ARTV) |
US |
$0.085B |
0.00 |
| Quince Therapeutics, Inc. (QNCX) |
US |
$0.084B |
0.00 |
| Atara Biotherapeutics, Inc. (ATRA) |
US |
$0.083B |
0.00 |
| InflaRx N.V. (IFRX) |
DE |
$0.083B |
0.00 |
| Precision BioSciences, Inc. (DTIL) |
US |
$0.081B |
0.00 |
| aTyr Pharma, Inc. (ATYR) |
US |
$0.080B |
0.00 |
| BeyondSpring Inc. (BYSI) |
US |
$0.079B |
0.00 |
| Fortress Biotech, Inc. (FBIO) |
US |
$0.078B |
0.00 |
| ALX Oncology Holdings Inc. (ALXO) |
US |
$0.074B |
0.00 |
| Repare Therapeutics (RPTX) |
Canada |
$0.073B |
0.00 |
| XBiotech (XBIT) |
United States |
$0.071B |
0.00 |
| Immunic, Inc. (IMUX) |
US |
$0.071B |
0.00 |
| ABVC BioPharma, Inc. (ABVC) |
US |
$0.071B |
0.00 |
| Sutro Biopharma (STRO) |
United States |
$0.069B |
0.00 |
| Adagene Inc. Sponsored ADR (ADAG) |
CN |
$0.066B |
0.00 |
| Coeptis Therapeutics Holdings, Inc. (COEP) |
US |
$0.066B |
0.00 |
| Equillium, Inc. (EQ) |
US |
$0.065B |
0.00 |
| CervoMed Inc. (CRVO) |
US |
$0.064B |
0.00 |
| Spruce Biosciences (SPRB) |
United States |
$0.064B |
0.00 |
| BioStem Technologies, Inc. (BSEM) |
|
$0.062B |
3.26 |
| TScan Therapeutics (TCRX) |
United States |
$0.062B |
0.00 |
| MiNK Therapeutics, Inc. (INKT) |
US |
$0.060B |
0.00 |
| Adlai Nortye Ltd. Sponsored ADR (ANL) |
KY |
$0.057B |
0.00 |
| Werewolf Therapeutics, Inc. (HOWL) |
US |
$0.056B |
0.00 |
| Cue Biopharma, Inc. (CUE) |
US |
$0.054B |
0.00 |
| Adicet Bio, Inc. (ACET) |
US |
$0.053B |
0.00 |
| Oncobiologics, Inc. (OTLK) |
US |
$0.053B |
0.00 |
| Senti Biosciences (SNTI) |
United States |
$0.051B |
0.00 |
| Annovis Bio, Inc. (ANVS) |
US |
$0.049B |
0.00 |
| Celularity, Inc. (CELU) |
US |
$0.048B |
0.00 |
| Skye Bioscience (SKYE) |
United States |
$0.047B |
0.00 |
| TELA Bio (TELA) |
United States |
$0.046B |
0.00 |
| Hyperion DeFi, Inc. (HYPD) |
US |
$0.045B |
0.00 |
| Kezar Life Sciences, Inc. (KZR) |
US |
$0.044B |
0.00 |
| Genenta Science S.p.A. Unsponsored ADR (GNTA) |
IT |
$0.044B |
0.00 |
| Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) |
US |
$0.044B |
0.00 |
| Aligos Therapeutics, Inc. (ALGS) |
US |
$0.043B |
0.00 |
| INmune Bio, Inc. (INMB) |
US |
$0.043B |
0.00 |
| PDS Biotechnology Corporation (PDSB) |
US |
$0.043B |
0.00 |
| Medicus Pharma Ltd (MDCX) |
US |
$0.043B |
0.00 |
| CalciMedica Inc. (CALC) |
US |
$0.042B |
0.00 |
| LAVA Therapeutics N.V. (LVTX) |
NL |
$0.042B |
0.00 |
| X4 Pharmaceuticals (XFOR) |
United States |
$0.042B |
0.00 |
| Mersana Therapeutics, Inc. (MRSN) |
US |
$0.042B |
0.00 |
| Xilio Therapeutics (XLO) |
United States |
$0.042B |
0.00 |
| Grace Therapeutics, Inc. (GRCE) |
CA |
$0.041B |
0.00 |
| BioAtla, Inc. (BCAB) |
US |
$0.040B |
0.00 |
| OnKure Therapeutics, Inc. (OKUR) |
US |
$0.040B |
0.00 |
| Radiopharm Theranostics Limited - Sponsored ADR (RADX) |
AU |
$0.039B |
0.00 |
| Elutia Inc. (ELUT) |
US |
$0.038B |
0.00 |
| Tvardi Therapeutics (TVRD) |
United States |
$0.038B |
0.00 |
| Rein Therapeutics (RNTX) |
United States |
$0.037B |
0.00 |
| Lantern Pharma Inc. (LTRN) |
US |
$0.037B |
0.00 |
| RenovoRx (RNXT) |
United States |
$0.035B |
0.00 |
| Sonnet BioTherapeutics Holdings (SONN) |
United States |
$0.034B |
0.00 |
| Generation Bio Co. (GBIO) |
US |
$0.034B |
0.00 |
| Quantum Biopharma Ltd. (QNTM) |
CA |
$0.034B |
0.00 |
| Femasys Inc. (FEMY) |
US |
$0.034B |
0.00 |
| Dyadic International Inc. (DYAI) |
US |
$0.034B |
0.00 |
| SAB Biotherapeutics (SABS) |
United States |
$0.033B |
0.00 |
| ImageneBio, Inc. (IMA) |
US |
$0.033B |
0.00 |
| Tenax Therapeutics (TENX) |
United States |
$0.032B |
0.00 |
| Tharimmune (THAR) |
United States |
$0.032B |
0.00 |
| AN2 Therapeutics, Inc. (ANTX) |
US |
$0.031B |
0.00 |
| Alterity Therapeutics Limited - Sponsored ADR (ATHE) |
AU |
$0.031B |
0.00 |
| BioXcel Therapeutics, Inc. (BTAI) |
US |
$0.029B |
0.00 |
| Synaptogenix (TAOX) |
United States |
$0.029B |
0.00 |
| Jasper Therapeutics, Inc. (JSPR) |
US |
$0.029B |
0.00 |
| MIRA Pharmaceuticals, Inc. (MIRA) |
US |
$0.028B |
0.00 |
| Q32 Bio Inc. (QTTB) |
US |
$0.028B |
0.00 |
| Boundless Bio, Inc. (BOLD) |
US |
$0.028B |
0.00 |
| Pluri Inc. (PLUR) |
IL |
$0.027B |
0.00 |
| iBio, Inc. (IBIO) |
US |
$0.027B |
0.00 |
| Rallybio (RLYB) |
United States |
$0.026B |
0.00 |
| CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN) |
IL |
$0.025B |
0.00 |
| Intensity Therapeutics Inc. (INTS) |
US |
$0.025B |
0.00 |
| Exicure (XCUR) |
United States |
$0.025B |
0.00 |
| Cadrenal Therapeutics, Inc. (CVKD) |
US |
$0.025B |
0.00 |
| Dare Bioscience, Inc. (DARE) |
US |
$0.025B |
0.00 |
| Lixte Biotechnology Holdings, Inc. (LIXT) |
US |
$0.024B |
0.00 |
| Moleculin Biotech, Inc. (MBRX) |
US |
$0.024B |
0.00 |
| NextCure, Inc. (NXTC) |
US |
$0.024B |
0.00 |
| Lexaria Bioscience Corp. (LEXX) |
CA |
$0.023B |
0.00 |
| MetaVia Inc. (MTVA) |
US |
$0.022B |
0.00 |
| Akari Therapeutics PLC (AKTX) |
GB |
$0.021B |
0.00 |
| Aytu BioPharma Inc. (AYTU) |
US |
$0.021B |
0.00 |
| Promis Neurosciences (PMN) |
CA |
$0.020B |
0.00 |
| Cingulate Inc. (CING) |
US |
$0.020B |
0.00 |
| Passage Bio, Inc. (PASG) |
US |
$0.020B |
0.00 |
| Clearside Biomedical, Inc. (CLSD) |
US |
$0.019B |
0.00 |
| Leap Therapeutics, Inc. (LPTX) |
US |
$0.019B |
0.00 |
| Synlogic (SYBX) |
United States |
$0.019B |
0.00 |
| FibroBiologics Inc. (FBLG) |
US |
$0.018B |
0.00 |
| Lisata Therapeutics, Inc. (LSTA) |
US |
$0.018B |
0.00 |
| Cuprina Holdings (Cayman) Limited (CUPR) |
SG |
$0.018B |
0.00 |
| Allarity Therapeutics, Inc. (ALLR) |
US |
$0.017B |
0.00 |
| Curis, Inc. (CRIS) |
US |
$0.016B |
0.00 |
| Hoth Therapeutics, Inc. (HOTH) |
US |
$0.016B |
0.00 |
| Apollomics Inc. (APLM) |
US |
$0.016B |
0.00 |
| Longeveron Inc. (LGVN) |
US |
$0.016B |
0.00 |
| Palisade Bio, Inc. (PALI) |
US |
$0.015B |
0.00 |
| GeoVax Labs Inc. (GOVX) |
US |
$0.015B |
0.00 |
| Athira Pharma, Inc. (ATHA) |
US |
$0.015B |
0.00 |
| Abpro Holdings Inc. (ABP) |
US |
$0.015B |
0.00 |
| Beyond Air (XAIR) |
United States |
$0.014B |
0.00 |
| BioCardia, Inc. (BCDA) |
US |
$0.014B |
0.00 |
| Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) |
IL |
$0.014B |
0.00 |
| Propanc Biopharma Inc (PPCB) |
AU |
$0.013B |
0.00 |
| Novogen Limited (KZIA) |
AU |
$0.012B |
0.00 |
| Dogwood Therapeutics, Inc (DWTX) |
US |
$0.012B |
0.00 |
| Edesa Biotech, Inc. (EDSA) |
CA |
$0.012B |
0.00 |
| Aspire Biopharma Holdings, Inc. (ASBP) |
US |
$0.012B |
0.00 |
| Sensei Biotherapeutics (SNSE) |
United States |
$0.011B |
0.00 |
| Cocrystal Pharma, Inc. (COCP) |
US |
$0.011B |
0.00 |
| IMMURON (IMRN) |
AU |
$0.011B |
0.00 |
| Biofrontera Inc. (BFRI) |
US |
$0.011B |
0.00 |
| Biorestorative Therapies, Inc. (BRTX) |
US |
$0.011B |
0.00 |
| Purple Biotech Ltd. Sponsored ADR (PPBT) |
IL |
$0.011B |
0.00 |
| Imunon, Inc. (IMNN) |
US |
$0.010B |
0.00 |
| Neuphoria Therapeutics Inc. (NEUP) |
AU |
$0.010B |
0.00 |
| Gelteq Limited (GELS) |
AU |
$0.010B |
0.00 |
| bioAffinity Technologies, Inc. (BIAF) |
US |
$0.009B |
0.00 |
| Mustang Bio, Inc. (MBIO) |
US |
$0.009B |
0.00 |
| Advanced Biomed Inc. (ADVB) |
US |
$0.009B |
0.00 |
| Bolt Biotherapeutics, Inc. (BOLT) |
US |
$0.009B |
0.00 |
| Silexion Therapeutics Corp (SLXN) |
Israel |
$0.009B |
0.00 |
| Sunshine Biopharma (SBFM) |
United States |
$0.008B |
0.00 |
| Avalon GloboCare Corp. (ALBT) |
US |
$0.008B |
0.00 |
| Creative Medical Technology Holdings, Inc. (CELZ) |
US |
$0.008B |
0.00 |
| BRIACELL THERAP (BCTX) |
CA |
$0.008B |
0.00 |
| Acurx Pharmaceuticals, Inc. (ACXP) |
US |
$0.008B |
0.00 |
| Alzamend Neuro, Inc. (ALZN) |
US |
$0.007B |
0.00 |
| Aprea Therapeutics, Inc. (APRE) |
US |
$0.007B |
0.00 |
| Adial Pharmaceuticals, Inc. (ADIL) |
US |
$0.007B |
0.00 |
| Mainz Biomed NV (MYNZ) |
DE |
$0.007B |
0.00 |
| IN8bio, Inc. (INAB) |
US |
$0.007B |
0.00 |
| Cardio Diagnostics Holdings, Inc. (CDIO) |
US |
$0.007B |
0.00 |
| Bionano Genomics, Inc. (BNGO) |
US |
$0.007B |
0.00 |
| Galecto, Inc. (GLTO) |
DK |
$0.007B |
0.00 |
| HCW Biologics Inc. (HCWB) |
US |
$0.007B |
0.00 |
| Entero Therapeutics, Inc. (ENTO) |
US |
$0.006B |
0.00 |
| Evogene Ltd. (EVGN) |
IL |
$0.006B |
0.00 |
| Silo Pharma (SILO) |
United States |
$0.006B |
0.00 |
| Ensysce Biosciences, Inc. (ENSC) |
US |
$0.006B |
0.00 |
| Soligenix (SNGX) |
United States |
$0.006B |
0.00 |
| VivoSim Labs (VIVS) |
United States |
$0.006B |
0.00 |
| Cyclerion Therapeutics, Inc. (CYCN) |
US |
$0.005B |
0.00 |
| GENPREX (GNPX) |
US |
$0.005B |
0.00 |
| Polyrizon Ltd. (PLRZ) |
IL |
$0.005B |
0.00 |
| Pasithea Therapeutics Corp. (KTTA) |
US |
$0.005B |
0.00 |
| Arcadia Biosciences (RKDA) |
United States |
$0.005B |
0.00 |
| KALA BIO, Inc. (KALA) |
US |
$0.005B |
0.00 |
| Aptevo Therapeutics Inc. (APVO) |
US |
$0.005B |
0.00 |
| Black Titan Corporation (BTTC) |
US |
$0.004B |
0.00 |
| Psyence Biomedical Ltd. (PBM) |
CA |
$0.004B |
0.00 |
| Onconetix, Inc. (ONCO) |
US |
$0.004B |
0.00 |
| GRI Bio, Inc. (GRI) |
US |
$0.004B |
0.00 |
| AquaBounty Technologies, Inc. (AQB) |
US |
$0.004B |
0.00 |
| Atrinsic Inc. (PTIX) |
US |
$0.004B |
0.00 |
| CNS Pharmaceuticals, Inc. (CNSP) |
US |
$0.004B |
0.00 |
| Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) |
GB |
$0.003B |
0.00 |
| Scinai Immunotherapeutics (SCNI) |
Israel |
$0.003B |
0.00 |
| Enveric Biosciences, Inc. (ENVB) |
US |
$0.003B |
0.00 |
| Bone Biologics Corp. (BBLG) |
US |
$0.003B |
0.00 |
| Revelation Biosciences, Inc. (REVB) |
US |
$0.002B |
0.00 |
| GT Biopharma, Inc. (GTBP) |
US |
$0.002B |
0.00 |
| Virax Biolabs Group (VRAX) |
United Kingdom |
$0.002B |
0.00 |
| Dermata Therapeutics, Inc. (DRMA) |
US |
$0.002B |
0.00 |
| Artelo Biosciences, Inc. (ARTL) |
US |
$0.002B |
0.00 |
| NuCana PLC Sponsored ADR (NCNA) |
GB |
$0.000B |
0.00 |
| Aceragen, Inc. (ACGN) |
US |
$0.000B |
0.00 |
| ARAVIVE, INC (ARAV) |
US |
$0.000B |
0.00 |
| Cellectis S.A. (CLLS) |
FR |
$0.000B |
0.00 |
| Clovis Oncology, Inc. (CLVSQ) |
US |
$0.000B |
0.00 |
| Celyad SA (CYAD) |
BE |
$0.000B |
0.00 |
| CytoMed Therapeutics Limited (GDTC) |
SG |
$0.000B |
0.00 |
| Galapagos NV (GLPG) |
BE |
$0.000B |
0.00 |
| IO Biotech, Inc. (IOBT) |
DK |
$0.000B |
0.00 |
| MediciNova, Inc. (MNOV) |
US |
$0.000B |
0.00 |
| Motif Bio Plc (MTFB) |
GB |
$0.000B |
0.00 |
| NeuroSense Therapeutics Ltd. (NRSN) |
IL |
$0.000B |
0.00 |
| PDL BioPharma, Inc. (PDLI) |
US |
$0.000B |
0.00 |
| Pulmatrix, Inc. (PULM) |
US |
$0.000B |
0.00 |
| TFF Pharmaceuticals (TFFP) |
United States |
$0.000B |
0.00 |
| VectivBio Holding AG (VECT) |
Switzerland |
$0.000B |
0.00 |
| YD Bio (YDES) |
|
$0.000B |
0.00 |
